Dr Swanson tells families that almost all kids get poxvirus-caused bumps and while treatment isn’t mandatory, options include topical cantharidin, berdazimer gel, and intralesional candida injections.
Q: My neighbor’s son was just diagnosed with a molluscum contagiosum rash. Is it safe for my neighbor's son to play with my son? A: Molluscum contagiosum (MC) is caused by a virus in the Poxviridae ...
There is a skin problem called molluscum contagiosum. It’s pretty common. Maybe you’ve heard of it. Maybe you or someone in your family has had it. This little condition with a big name is annoying, ...
12don MSN
HealthWatch - Molluscum contagiosum
Dr. Cara Hamilton with Black Hills Pediatrics tells you all you need to know about a sometimes worrying skin condition in this week’s edition of HealthWatch.
Topical cantharidin (Ycanth) was approved as the first treatment specifically for molluscum contagiosum, the FDA announced. Molluscum contagiosum is a viral skin infection that affects as many as 6 ...
Alphyn Biologics, Inc., a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics(R) , today announced dosing of the first patients in its Phase 2 clinical trial of ...
Please provide your email address to receive an email when new articles are posted on . The approval was based on results from two phase 3 randomized, double-blind, multicenter trials, CAMP-1 and CAMP ...
Please provide your email address to receive an email when new articles are posted on . The FDA has accepted a new drug application for Novan’s berdazimer gel for the treatment of molluscum ...
Molluscum contagiosum (MC), a viral skin infection caused by the poxvirus, often presents challenges in treatment due to limited therapeutic options. However, a potential breakthrough has emerged with ...
Molluscum contagiosum is a prevalent viral skin infection, particularly in children, that presents as small, firm, flesh-coloured papules. Although the condition is typically self‐limiting, its ...
Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin diseases requiring medical interventions, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results